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Heart assembly requires input from two populations
of progenitor cells, the first and second heart fields
(FHF and SHF), that differentiate at distinct times
and create different cardiac components. The car-
diac outflow tract (OFT) is built through recruitment
of late-differentiating, SHF-derived cardiomyocytes
to the arterial pole of the heart. The mechanisms
responsible for selection of an appropriate number
of OFT cells from the SHF remain unclear. Here, we
find that cell adhesion molecule 4 (cadm4) is essen-
tial for restricting the size of the zebrafish OFT.
Knockdown of cadm4 causes dramatic OFT expan-
sion, and overexpression of cadm4 results in a
greatly diminished OFT. Moreover, cadm4 activity
limits the production of OFT progenitor cells and
the duration of their accumulation at the arterial
pole. Together, our data suggest a role for cell adhe-
sion in restraining SHF deployment to the OFT,
perturbation of which could cause congenital OFT
defects.
INTRODUCTION
The vertebrate heart is built from two sources of cardiac progen-
itor cells—the first heart field (FHF) and second heart field
(SHF)—that differ in their timing of differentiation and in their con-
tributions to specific regions of the heart (Kelly, 2012). First,
cardiomyocytes (CMs) arising from the FHF create the primitive
heart tube. Later, the poles of this tube grow through the pro-
gressive recruitment of newly formed CMs that are derived
from the SHF. The SHF serves as an integral reservoir of devel-
opmental potential and is composed of proliferative progenitor
cells poised to contribute to the heart when the timing is right
(Hutson et al., 2010; Tirosh-Finkel et al., 2010; van den Berg
et al., 2009). It is therefore important to understand the network
of signals that control SHF deployment and ensure that the
appropriate populations differentiate in a timely fashion.
The cardiac outflow tract (OFT) is an example of a crucial SHF-
derived structure: a correctly elongated, properly oriented, and
accurately subdivided OFT is essential for effective connection
of the heart to the vasculature. Since many cases of congenitalheart disease feature OFT malformations (Neeb et al., 2013),
regulation of OFT dimensions has great clinical importance.
OFT formation begins with assembly of a small tube of myocar-
dium at the arterial pole of the heart (Buckingham et al., 2005;
Dyer and Kirby, 2009a). This myocardial foundation is built by
late-differentiating, SHF-derived progenitor cells that reside in
the pharyngeal mesoderm before they are recruited into the
OFT. Although the SHF origin of OFT CMs has been clearly es-
tablished, the precise molecular mechanisms responsible for
generating the proper number of OFT CMs from this progenitor
pool remain unclear.
Among the pathways that have been implicated in the regula-
tion of SHF development (Rochais et al., 2009), Fgf signaling has
a central role in driving OFT CM formation. In the early embryo,
Fgf signaling plays an integral part in heart field induction, coun-
terbalanced by retinoic acid signaling that limits field dimensions
(Ryckebusch et al., 2008; Sirbu et al., 2008; Sorrell andWaxman,
2011; Witzel et al., 2012). Later, Fgf signaling within the SHF reg-
ulates proliferation, survival, and deployment of OFT progenitor
cells (Ilagan et al., 2006; Park et al., 2006, 2008; Watanabe
et al., 2010). Several other signals, including Hedgehog and
Bmp (Dyer and Kirby, 2009b; Hami et al., 2011; Hutson et al.,
2010; Prall et al., 2007; Tirosh-Finkel et al., 2010), collaborate
with Fgf signaling to regulate OFT CM formation. However, the
mechanisms that restrain production of OFT CMs from the
SHF remain poorly understood.
Here, we show that the gene cell adhesion molecule 4 (cadm4)
has a potent role in restricting the size of the OFT. Members of
the Cadm family of type I transmembrane proteins (also known
as SynCAM, Tsl, Igsf4, or Necl proteins) contain three extracel-
lular immunoglobulin (Ig)-like domains, a single-pass transmem-
brane domain, and a short cytoplasmic domain with both
4.1B-binding and PDZ-binding interaction motifs (Biederer,
2006). Through heterophilic extracellular interactions between
family members, Cadms are known to act as cell adhesion mol-
ecules in several contexts, including myelination and synapto-
genesis (Biederer et al., 2002; Maurel et al., 2007; Spiegel
et al., 2007), but the roles of Cadms during heart development
have not been previously examined.
In zebrafish, we find that cadm4 is expressed near the arterial
pole, where SHF-derived OFT progenitor cells reside. Strikingly,
loss of cadm4 function causes dramatic enlargement of the OFT,
whereas gain of cadm4 function results in a diminished OFT.
Alteration in the number of OFT CMs is preceded by alterations
in the proliferation, accumulation, and perdurance of OFTCell Reports 7, 951–960, May 22, 2014 ª2014 The Authors 951
Figure 1. Fgf Signaling Promotes Formation of OFT Progenitor Cells
(A and F) Hearts at 48 hpf, frontal views, arterial pole up, stained with MF20 (red) and S46 (green) antibodies to visualize the OFT (red, bracket), ventricle (red), and
atrium (yellow). The OFT is morphologically evident in control DMSO-treated embryos (A) and absent in embryos treated with 10 mMSU5402 from 24 to 48 hpf (F).
(B–E and G–J) In situ hybridization highlights the presumed OFT progenitor cells adjacent to the arterial pole at 30 hpf. Dorsal views (B, C, G, and H) and lateral
views (D, E, I, and J), arterial pole up; (C–E and H–J) partial reconstructions of confocal z stacks. The presumed OFT progenitors (brackets) express low levels of
myl7 (blue, B) and vmhc (green, C); very few of these cells are found in embryos treated with SU5402 from 24 to 30 hpf (G and H). Expression ofmef2cb (green, D)
and ltbp3 (green, E) is visible in the progenitor cells (arrowheads) residing next to the differentiated myocardium of the heart tube (MF20, red); this population is
barely detectable in SU5402-treated embryos (I and J).
(K–M) Fluorescent in situ hybridization shows that cadm4 (green, K) is expressed in the region where OFT progenitor cells are thought to reside (arrowheads), as
well as in neuronal tissues as previously reported (Pietri et al., 2008). vmhc (green, L) and nkx2.5 (green, M) are expressed at low levels within the same region
(arrowheads), as well as at high levels throughout the heart tube. Differentiated myocardium is marked by MF20 (red); partial reconstructions of lateral views at
28 hpf.
Scale bars, 50 mm. See also Figure S1 and Table S1.progenitor cells, indicating an important function of cadm4 in
limiting recruitment of progenitors from the SHF to the arterial
pole. Together, our results suggest a model in which modulation
of cadm4 function alters critical extracellular interactions that
dictate the dynamics of SHF deployment, perturbation of which
could cause congenital defects in OFT formation.
RESULTS
Fgf Signaling Promotes Formation of OFT Progenitor
Cells
To enhance our understanding of OFT size regulation, we sought
to identify genes with a potent impact on production of OFT pro-
genitor cells. Our prior studies showed that Fgf signaling plays an952 Cell Reports 7, 951–960, May 22, 2014 ª2014 The Authorsessential role in promoting formation of OFT CMs in zebrafish (de
Pater et al., 2009), just as it does in amniotes (Ilagan et al., 2006;
Park et al., 2006). Zebrafish fgf8a mutants exhibit a small
ventricle and lack an evident OFT, and temporally controlled
inhibition of Fgf signaling can dissociate two distinct roles of
this pathway: an early requirement for the initial specification of
ventricular progenitors and a later requirement for the production
of OFT CMs (de Pater et al., 2009; Marques et al., 2008). Treat-
ment with the Fgfr antagonist SU5402 from 24 hr postfertilization
(hpf) inhibits OFT formation (Figures 1A and 1F) (de Pater et al.,
2009). Moreover, the absence of an evident OFT in SU5402-
treated embryos is preceded by diminished expression of
markers associated with OFT progenitor cells (Figures 1B–1E
and 1G–1J). In wild-type embryos, myl7, vmhc, and nkx2.5 are
strongly expressed within differentiated CMs and faintly ex-
pressed in an adjacent population of cells presumed to contain
SHF-derived OFT progenitors (Figures 1B, 1C, 1L, and 1M)
(Lazic and Scott, 2011; Zhou et al., 2011). Cells within this adja-
cent population also express high levels of mef2cb and ltbp3
(Figures 1D and 1E), both of which are thought to mark undiffer-
entiated SHF-derived cells (Lazic and Scott, 2011; Zhou et al.,
2011). In SU5402-treated embryos, these markers are substan-
tially downregulated near the arterial pole (Figures 1G–1J),
consistent with prior findings (Lazic and Scott, 2011). Similar
phenotypes are seen in fgf8a mutants (Figures S1A and S1B).
These data suggest that loss of the OFT in embryos lacking
Fgf signaling reflects a requirement for Fgf signaling in promotion
of the normal formation of OFT progenitor cells.
Cadm4 Restricts the Number of OFT CMs
Given that Fgf signaling has a profound effect on the develop-
ment of OFT progenitor cells, we took advantage of SU5402-
treated embryos as a platform for discovering genes involved
in OFT progenitor production. We dissociated hearts from
SU5402-treated embryos and control siblings and compared
their gene-expression profiles. Of the differentially expressed
genes (Table S1), wewere particularly intrigued by cadm4, which
is expressed near the arterial pole in the region where OFT
progenitor cells are thought to reside (Figures 1K–1M) and was
upregulated in SU5402-treated embryos (Table S1; Figures
S1C and S1D).
To investigate the role of cadm4 during OFT development, we
used morpholinos (MOs) to knock down cadm4 function. Strik-
ingly, we found that embryos injected with these MOs (referred
to as cadm4 morphants) exhibit a dramatically elongated OFT
(Figures 2A–2D). Similar effects were seen with each of three
nonoverlapping MOs (Figures S2A–S2D). Using fluorescent re-
porter transgenes to assess the timing of myocardial differentia-
tion (see Experimental Procedures), we determined that the
elongated OFT in cadm4 morphants, like the wild-type OFT,
was composed of late-differentiating CMs (Figures 2J–2O), as
opposed to containing early-differentiating ventricular cells that
were displaced into the OFT. Additionally, we found that elonga-
tion of the OFT in cadm4morphants was a consequence of their
containing approximately twice the normal number of late-differ-
entiating CMs (Figure 2I), rather than simply being the result of
altered OFT cell size. As was the case for the wild-type OFT, for-
mation of this expanded OFT required Fgf signaling: treatment
with SU5402 dramatically reduced OFT size in both control
and cadm4 morphant embryos (Figures S2H–S2T). In contrast
to their excess of OFT CMs, cadm4 morphants displayed rela-
tively normal numbers of ventricular and atrial CMs (Figure 2I);
in addition, their heart rate and circulation were comparable to
those of control siblings (Movies S1 and S2). Together, these re-
sults indicate an important role for Cadm4 in limiting OFT size.
In complementary experiments, we found that increased
levels of cadm4 expression reduced the size of theOFT. Injection
of cadm4 mRNA resulted in loss of an evident OFT (Figures 2E–
2H), and our developmental timing assay revealed that overex-
pression of cadm4 reduced the number of late-differentiating
CMs (Figures 2P–2R; 32 ± 2 CMs in control embryos [n = 5]
and 17 ± 5 CMs in embryos overexpressing cadm4 [n = 6]).Together with our loss-of-function data, these experiments sug-
gest that levels of Cadm4 activity are critical for determining the
number of late-differentiating CMs that form the OFT.
Cadm4 Delimits the Number of OFT Progenitor Cells
The impact of cadm4 activity on the size of the OFT could reflect
an early influence of cadm4 on the dimensions of the OFT pro-
genitor pool or a later influence of cadm4 on the proliferation of
OFT CMs. To evaluate early effects of cadm4 function on
the OFT progenitor population, we examined markers of SHF-
derived progenitor cells at stages prior to OFT formation. This
progenitor population appeared to be substantially enlarged in
cadm4 morphants (Figures 3A, 3B, 3D, 3E, 3J, and S3A–S3H),
in contrast to the reduction in progenitors observed when Fgf
signaling was deficient (Figures 1G–1J). For example, mef2cb
expression was visibly expanded in the territory adjacent to the
arterial pole of the cadm4 morphant heart tube (Figures 3A and
3B). This expansion was visible as early as 24 hpf (Figures
S3C–S3F), aswere similar expansions of vmhc and ltbp3 expres-
sion (Figures S3A, S3B, S3G, and S3H). In addition, cadm4mor-
phants displayed a significantly larger number of cells near the
arterial pole that expressed the transgene Tg(nkx2.5:ZsYellow),
but did not yet express markers of differentiated myocardium
(Figures 3D, 3E, and 3J).
In contrast to the expanded population of OFT progenitor cells
in cadm4 morphants, we found that embryos overexpressing
cadm4 possessed a notably reducedOFT progenitor population.
Overexpression of cadm4 resulted in diminished expression of
mef2cb and ltbp3 near the arterial pole (Figures 3A, 3C, S2U,
and S2W), and cadm4-overexpressing embryos exhibited signif-
icantly fewer undifferentiated Tg(nkx2.5:ZsYellow)-expressing
cells in this territory (Figures 3D, 3F, and 3J). These decreases
in the OFT progenitor population are consistent with the diminu-
tive OFT size observed in cadm4-overexpressing embryos
(Figures 2H and 2R). Furthermore, overexpression of cadm4
interfered with the ability of elevated Fgf signaling to expand
the OFT progenitor population (Figures S2U–S2X), highlighting
the potency of cadm4 activity. Together, the converse effects
of cadm4 loss-of-function and gain-of-function suggest an
important and early role of Cadm4 in delimiting the pool of OFT
progenitor cells.
Although cadm4 morphants possessed an enlarged popula-
tion of progenitor cells adjacent to the arterial pole (Figure 3J),
the proliferation index of this proximal population, as measured
by a 5-ethynyl-20-deoxyuridine (EdU) incorporation assay
between 22 and 24 hpf, was comparable between cadm4 mor-
phants and control siblings (Figure 3K). Similarly, as the heart
tube lengthened, we found no evidence of increased prolifera-
tion in the differentiated CMs that formed the OFT in cadm4mor-
phants (Figures S3I and S3J). Instead, the number of proliferating
OFTCMs appeared to be proportional to the total number of OFT
CMs in both cadm4 morphants and control siblings (Figures
S3K–S3P). Therefore, it seems that cadm4 delimits OFT size
primarily by delimiting the number of OFT progenitor cells, rather
than by regulating proliferation of OFT progenitors located prox-
imal to the arterial pole or proliferation of differentiated CMs
within the OFT. Consistent with this, the near doubling of the
proximal progenitor population in cadm4 morphants at 24 hpfCell Reports 7, 951–960, May 22, 2014 ª2014 The Authors 953
Figure 2. Cadm4 Activity Limits OFT Size
(A–D) Reduced cadm4 function results in an enlarged OFT.
(A and B) Lateral views of embryos at 48 hpf. Injection of an anti-cadm4 MO (B) does not disrupt general embryonic morphology.
(C and D) Hearts at 48 hpf, as in Figure 1A. Compared with the normal length of the OFT (bracket, C) in control sibling embryos, the OFT in cadm4morphants is
abnormally elongated (bracket, D).
(E–H) Elevated levels of cadm4 function result in reduced OFT size.
(E and F) Lateral views of embryos at 26 hpf. Injection of cadm4 mRNA (F) causes slight shortening of the body axis.
(G and H) Hearts at 48 hpf, as in (C). Rather than exhibiting normal OFT size (bracket, G), embryos injected with cadm4 mRNA exhibit very little OFT tissue
(bracket, H).
(I) Number of ventricular, atrial, and OFT CMs in control and cadm4morphant hearts at 48 hpf; the graph displays mean and SD for each data set. Although the
numbers of ventricular and atrial CMs are unaffected in cadm4 morphants, the OFT in cadm4 morphants has more CMs than the OFT in control siblings (*p <
0.0005; n = 5).
(J–R) Single confocal slices through Tg(myl7:EGFP);Tg(myl7:DsRedt4) hearts at 48 hpf, arterial pole up. These transgenes can distinguish early-differentiating
CMs (EGFP and DsRed) from late-differentiating CMs (EGFP only, dotted outlines). Compared with controls (J–L), cadm4 morphants have an excess of
late-differentiating CMs (M–O), and embryos injected with cadm4 mRNA have a deficit of late-differentiating CMs (P–R).
Scale bars, 300 mm in (A) and (E), 50 mm in (D), (H), and (P). See also Figure S2 and Movies S1 and S2.
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seems sufficient to account for the comparable increase in OFT
size at 48 hpf (Figures 2I and 3J).
We wondered whether the increased number of OFT progen-
itor cells in cadm4 morphants could be the consequence of
excess progenitor proliferation prior to their recruitment to the
arterial pole. In amniotes, SHF-derived cells that will contribute
to the OFT first reside in a distal pharyngeal region where they
are maintained in a proliferative state before they proceed to
differentiate and move into the heart (Hutson et al., 2010;
Tirosh-Finkel et al., 2010; van den Berg et al., 2009). In zebrafish,
it has not been shownwhether SHF-derived cells travel through a
parallel region on their route to the OFT. In this regard, it is
interesting to note that our EdU incorporation assays revealed
an effect of cadm4 on the proliferation of a population of
Tg(nkx2.5:ZsYellow)-expressing cells located distal to the arte-
rial pole (Figures 3L–3Q). In contrast to the Tg(nkx2.5:ZsYellow)-
expressing cells that were tightly clustered proximal to the heart
tube (Figures 3D–3F), the distal population of cells was more
dispersed and expressed a lower level of Tg(nkx2.5:ZsYellow)
(Figures 3L–3N). These traits also distinguish the distal
Tg(nkx2.5:ZsYellow)-expressing cells from the bilateral clusters
of Tg(nkx2.5:ZsYellow)-expressing pharyngeal mesendoderm
that flank this medially located population (Paffett-Lugassy
et al., 2013) (Figures 3L–3N). Our data demonstrate that the num-
ber of distal Tg(nkx2.5:ZsYellow)-expressing cells is not affected
when levels of cadm4 function are altered (Figure 3P). However,
the proliferation index of this population is significantly increased
in cadm4 morphants and decreased in cadm4-overexpressing
embryos (Figure 3Q). Furthermore, photoconversion of distal
Tg(nkx2.5:kaede)-expressing cells demonstrates that this popu-
lation contains progenitor cells that contribute to the OFT
myocardium (Figures 3R–3Z). Thus, our data suggest that
cadm4 limits the proliferation of OFT progenitor cells prior to their
deployment to the arterial pole, thereby restricting the dimen-
sions of the OFT progenitor population.
Cadm4 Curtails Recruitment of Progenitor Cells to the
Arterial Pole
In addition to regulating the number of OFT progenitor cells that
accumulate at the arterial pole, cadm4 also appears to regulate
the perdurance of progenitor cells in this location. In wild-type
embryos, the expression of OFT progenitor markers, such as
mef2cb and ltbp3, declines as OFT CM differentiation proceeds
and is ultimately extinguished once differentiation is complete
(Lazic and Scott, 2011; Zhou et al., 2011) (Figures 4A–4D). Strik-
ingly, in cadm4 morphants, expression of mef2cb and ltbp3 is
not only spatially expanded but also temporally extended (Fig-
ures 4E–4H). Even at 48 hpf, when expression of mef2cb and
ltbp3 is nearly undetectable in the wild-type OFT, these genes
are still robustly expressed around the arterial pole in cadm4
morphants (Figures 4B, 4D, 4F, and 4H).
The persistence of OFT progenitor gene expression in cadm4
morphants suggested the possibility that cadm4 function is
necessary for the normal termination of recruitment of late-differ-
entiating cells to the OFT. Prior studies that used a photoconver-
tible fluorescent reporter transgene to monitor the timing of
myocardial differentiation indicated that nearly all OFT CMs had
undergone differentiation by 36 hpf (Lazic and Scott, 2011).Employing a similar transgene (see Experimental Procedures),
we found that cadm4morphants continued to addnewly differen-
tiating OFT CMs after 37 hpf (Figures 4L–4N), whereas no new
differentiation of OFT CMs was evident after this time point in
wild-type embryos (Figures 4I–4K). Prolonged addition of OFT
CMswasalsoobserved incadm4morphants at even later stages:
using both of our assays for timing of differentiation (Figures 2J–
2L and 4I–4K), we found evidence for initiation of differentiation
of OFT CMs in cadm4morphants after 48 hpf (Figure S4).
Together, our data indicate that Cadm4 plays an important
role in curtailing the recruitment of progenitor cells into the
OFT. Cadm4 is required to limit the number of OFT progenitor
cells at the arterial pole, the persistence of OFT progenitor
markers, and the duration of the time frame for OFT CM differen-
tiation. Collectively, these functions of Cadm4 account for its
potent impact on restricting the size of the OFT.
DISCUSSION
Our studies reveal an important role for cadm4 in regulating OFT
size. When cadm4 function is reduced, surplus OFT progenitors
accumulate at the arterial pole and persist over an extended
period of time, creating an abnormally elongated OFT. When
cadm4 levels are elevated, recruitment of OFT progenitors is
notably deficient. Thus, our data indicate that downregulation
of cadm4 activity facilitates SHF deployment and promotes the
formation of OFT CMs. This discovery provides insight into the
balance between the positive and negative influences that deter-
mine the number of CMs emerging from the SHF. While several
signals are known to stimulate the production of OFT progenitor
cells, the function ofcadm4provides an important demonstration
of a pathway that stems the flow of cells from the SHF to theOFT.
The pipeline of OFT CM production involves the specification,
proliferation, andmaintenance of progenitor cells within the SHF,
their subsequent deployment to the arterial pole, and their differ-
entiation into CMs. Our data suggest that cadm4 limits progen-
itor deployment by restraining the proliferation of OFT progenitor
cells prior to their recruitment to the arterial pole. Although the
distal Tg(nkx2.5:ZsYellow)-expressing cells may not be the only
source of OFT progenitors, this scenario could account for the
impact of cadm4 on the rate and duration of OFT progenitor
accumulation: excess proliferation and deployment could create
an overcrowded pipeline and lead to an overextended timeline
for the addition of late-differentiating CMs. Overall, our results
are consistent with a model in which levels of Cadm4 activity,
regulated by Fgf signaling, act to control the number of OFT pro-
genitor cells that emerge from the SHF. Future studies will be
valuable to dissect the precise interface between Fgf signaling
and Cadm4 expression, and to determine how directly or indi-
rectly Cadm4 influences progenitor proliferation.
Contacts between myelinating Schwann cells and axons are
mediated by heterophilic binding between the extracellular do-
mains of glial Cadm4 and axonal Cadm3, and disruption of this
interaction leads to reduced myelination (Maurel et al., 2007;
Spiegel et al., 2007). Extrapolating from this and other estab-
lished roles of Cadms, we propose that Cadm-mediated extra-
cellular interactions in the SHF are crucial for regulating OFT pro-
genitor production. Adhesion between tissue-specific stem cellsCell Reports 7, 951–960, May 22, 2014 ª2014 The Authors 955
Figure 3. Cadm4 Limits Formation of OFT Progenitor Cells
(A–C) In situ hybridization shows expression ofmef2cb (green) in progenitor cells adjacent to the differentiatedmyocardium (MF20, red); partial reconstructions of
dorsal views at 30 hpf, arterial pole up. In comparison with control embryos (A), this progenitor population (arrowheads) is expanded in cadm4morphants (B) and
reduced in embryos overexpressing cadm4 (C).
(D–I) Partial reconstructions of dorsal views of arterial poles expressing Tg(nkx2.5:ZsYellow) (yellow, D–F) at 24 hpf; MF20 (red, D–I) marks differentiated CMs. In
control embryos (D and G), undifferentiated progenitor cells (yellow, not red; arrows indicate examples) cluster in a proximal region adjacent to the arterial pole.
This population is expanded in cadm4 morphants (E) and reduced in embryos overexpressing cadm4 (F).
(J) Number of ZsYellow+MF20 OFT progenitor cells in the proximal region at 24 hpf in control embryos, cadm4 morphants, and embryos injected with cadm4
mRNA; asterisks indicate statistically significant differences from controls (p < 0.0001; n = 9–14). Comparable progenitor surpluses resulted from injection of
either of two nonoverlapping MOs (52 ± 6 cells, ATG MO1 [n = 14]; 58 ± 6 cells, splice MO [n = 7]).
(K) Proliferation indexes are comparable for the proximal OFT progenitor cells in control embryos and cadm4 morphants.
(L–N) Partial reconstructions of dorsal views of the region near the arterial pole in embryos expressing Tg(nkx2.5:ZsYellow) at 24 hpf; images were captured with a
higher gain than in (D)–(F). Squares indicate the regiondefined asdistal in representative control (L),cadm4morphant (M), and cadm4-overexpressing (N) embryos.
(legend continued on next page)
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and their surrounding niches has been shown to be influential in
several other contexts (Marthiens et al., 2010), but no such niche
has been documented within the SHF. Our studies suggest the
possibility that downmodulation of Cadm4 levels alters the inter-
actions between progenitor cells and their niche, and influences
the dynamics of progenitor proliferation and deployment. Further
evaluation of this model will benefit from examining where and
when interactions between Cadm family members occur in the
distal territory, and in this regard, it is intriguing that cadm2a,
like cadm4, is upregulated in SU5402-treated embryos (Table
S1). Alternatively, Cadm4 may influence OFT progenitor produc-
tion through interactions with other signaling pathways. In cell
culture, for example, Cadm4 has been shown to interact in cis
with ErbB receptors (Sugiyama et al., 2013).
Altogether, our data suggest a paradigm in which extracellular
interactions mediated by cell adhesion molecules are essential
for controlling the deployment of SHF-derived progenitor cells.
It is particularly interesting to consider whether the function of
Cadms during SHF deployment is conserved across species.
Evaluation of the cardiac role of mammalian Cadms awaits
construction of appropriate mouse models (Golan et al., 2013).
Our studies also raise the intriguing notion that cell adhesion
molecules and even specific CADM genes could be relevant to
the etiology of human congenital heart disease. Furthermore,
modulation of cell adhesion or Cadm function could prove to
be a valuable strategy for controlling the production of CMs
from multipotent cells in vitro.
EXPERIMENTAL PROCEDURES
The protocols used for SU5402 treatment, injection, immunofluorescence,
in situ hybridization, imaging, microarray analysis, RT-PCR, heat shock, and
photoconversion are provided in Supplemental Experimental Procedures.
Zebrafish
We used zebrafish carrying the transgenes Tg(5.1myl7:nDsRed2)f2 (Mably
et al., 2003), Tg(myl7:EGFP)twu277 (Huang et al., 2003), Tg(myl7:DsRedt4)sk74
(Garavito-Aguilar et al., 2010), Tg(myl7:kaede)sd22 (de Pater et al., 2009),
Tg(hsp70:ca-fgfr1)pd3 (Marques et al., 2008), Tg(nkx2.5:ZsYellow)fb7 (Zhou
et al., 2011), and Tg(nkx2.5:kaede)fb9 (Guner-Ataman et al., 2013), as well as
zebrafish carrying the mutation fgf8ati282a (Reifers et al., 2000). All zebrafish
work followed protocols approved by the Institutional Animal Care and Use
Committee.
Cell Counting and Developmental Timing Assays
We used two complementary developmental timing assays to monitor late-
differentiating CMs. For qualitative assessment, we used an established(O and O’) EdU incorporation (red) in an embryo expressing Tg(nkx2.5:ZsYellow
(arrows) in this representative slice.
(P) The numbers of Tg(nkx2.5:ZsYellow)-expressing cells in the distal regions o
(n = 7–12).
(Q) The proliferation index is increased in the distal Tg(nkx2.5:ZsYellow)-expres
population in cadm4-overexpressing embryos (*p < 0.0001).
(R–W) Single slices show dorsal views near the arterial pole in a representative Tg
of a portion of the distal region (rectangle) containing approximately ten Tg(nkx2.5
generated using the ‘‘surface’’ function in Imaris to highlight cells expressing low
(X–Z) Single slices show lateral views of Tg(nkx2.5:kaede) expression in the heart a
have become OFT CMs. Dots (X and Y) outline the ventral wall of the forming O
photoconverted cells within the green OFT myocardium. Similar results were ob
Bar graphs display mean and SD for each data set. Scale bars, 50 mm. See alsophotoconversion protocol in Tg(myl7:kaede) embryos (de Pater et al., 2009).
Photoconversion of green Kaede protein through exposure to UV light creates
red Kaede protein in all differentiated CMs. Subsequently, newly differentiated
CMs added since the time of photoconversion will fluoresce green, but not red,
and can be distinguished from CMs that were present when photoconversion
occurred.
For quantitative assessment, we used a version of an established assay that
takes advantage of the temporal difference in maturation of EGFP and DsRed
(de Pater et al., 2009). Since DsRed takes longer to mature than EGFP, CMs in
Tg(myl7:EGFP);Tg(myl7:DsRedt4) embryos show green fluorescence before
they show red fluorescence. Newly differentiated CMs will fluoresce green,
but not red, and can be distinguished from CMs that differentiated earlier; at
48 hpf, all wild-type OFT CMs fluoresce green, but not red (Figures 2J–2L).
To count green, but not red, OFT CMs, we used DAPI to label nuclei and the
‘‘spot’’ function in Imaris to distinguish individual cells in reconstructions of
confocal z stacks. To count ventricular and atrial CMs, we used
Tg(5.1myl7:nDsRed2) embryos and the antibody S46, as in our previous
work (Marques et al., 2008).
EdU Incorporation
We modified established protocols for EdU incorporation assays (Cheesman
et al., 2011; Mahler et al., 2010). Embryos were incubated in 10 mM EdU
(Invitrogen) in 0.33 Danieau buffer with 10% DMSO for 20 min on ice. After
a series of Danieau washes, the embryos were incubated at 28.5C until
fixation. We then used a Click-iT Imaging kit (Invitrogen) to visualize EdU
incorporation. Stained embryos were stored in SlowFade Gold antifade
reagent with DAPI (Molecular Probes).
To evaluate proliferation of Tg(nkx2.5:ZsYellow)-expressing cells (Figures
3D–3Q), we exposed embryos to EdU at 22 hpf and fixed them at 24 hpf. To
analyze the proximal population (Figures 3D–3K), we counted the number of
ZsYellow+MF20 cells adjacent to the arterial pole. To analyze the distal
population (Figures 3L–3Q), we counted the number of ZsYellow+ cells in a
150-mm-wide square positioned 30 mm distal to the heart tube. For each
population, we calculated the proliferation index as the percentage of cells
that incorporated EdU.
Statistical Analysis
To compare data sets, we used Prism software (GraphPad) to perform
Student’s t test with two-tail distribution. Graphs display mean and SD for
each data set.
ACCESSION NUMBERS
The GEO accession number for the microarray data reported in this paper is
GSE55540.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, one table, and twomovies and can be foundwith this article online
at http://dx.doi.org/10.1016/j.celrep.2014.04.013.) (yellow); EdU is visible in at least two Tg(nkx2.5:ZsYellow)-expressing cells
f control, cadm4 morphant, and cadm4-overexpressing embryos are similar
sing cells in cadm4 morphants (*p < 0.0005) and is decreased in the same
(nkx2.5:kaede) embryo at 26 hpf, before (R–T) and after (U–W) photoconversion
:kaede)-expressing cells (green in T, red in W). Enhanced views (T and W) were
levels of Tg(nkx2.5:kaede).
t 30 hpf and indicate that three or four of the photoconverted cells (red, arrows)
FT. Bright-field image and magnified inset (Z) show the incorporation of red
tained in four independent embryos.
Figures S2 and S3.
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Figure 4. Cadm4 Curtails Addition of Late-Differentiating Cells to the Arterial Pole
(A–H) Expression ofmef2cb (A, B, E, and F) and ltbp3 (C, D, G, and H) juxtaposed with staining of differentiated myocardium (as in Figures 1D and 1E) at 36 (A, C,
E, and G) and 48 (B, D, F, and H) hpf; partial reconstructions (A, B, E, and F) or single slices (C, D, G, and H) of lateral views.
(A–D) In control embryos, expression of both genes (arrowheads) becomes extinguished as OFT differentiation reaches completion.
(E–H) In contrast, expression of both genes (arrowheads) is expanded and prolonged in cadm4 morphants.
(I–N) Single slices of lateral views of Tg(myl7:kaede)-expressing hearts at 50 hpf, following photoconversion at 37 hpf. Comparison of green fluorescence (I and L)
and red fluorescence (J and M) reveals the presence of late-differentiating cells (green, not red; dotted outlines).
(I–K) Control embryos do not exhibit addition of late-differentiating cells between 37 and 50 hpf (n = 34).
(L–N) In contrast, cadm4 morphants exhibit a population of green, but not red, OFT cells that initiated differentiation during this time frame (n = 42).
Scale bars, 50 mm. See also Figure S4.
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